Article 19 Mar 2018 Determining Venue For ANDAs Containing Paragraph IV Certification United States IP
Article 19 Mar 2018 Delaware Court Applies Acorda "Acts Of Infringement" Definition To Post-TC Heartland Venue Analysis United States Litigation
Article 06 Dec 2017 Unknown Problem Plus Nonobvious Solution Cannot Render Patent For Sublingual Formulation Of Asenapine Obvious United States IP
Article 22 Aug 2017 Supply and Purchase Agreement Triggers On-Sale Bar Provision of 35 USC § 102(b) United States IP
Article 11 Nov 2016 Hikma Successfully Moves To Dismiss Takeda's Induced Infringement Claims After Commercially Launching Its Mitigare® Drug For The Prevention Of Gout Flares United States IP
Article 25 Jul 2016 180-Day Notice Period For Biosimilar Approval Is Always Mandatory And Enforceable By Injunction United States IP
Article 30 Oct 2015 A No-AG Settlement Agreement Is Subject To Actavis' Rule Of Reason Analysis United States IP
Article 31 Dec 2013 Old Compound + Known Purpose + Prior Art Concentrations = Obvious United States IP